Evidence map›Paper›PMID 28886443›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2017

Antiplasmodial activities of dyes against Plasmodium falciparum asexual and sexual stages: Contrasted uptakes of triarylmethanes Brilliant green, Green S (E142), and Patent Blue V (E131) by erythrocytes.

Louis-Jérôme Leba, Jean Popovici, Yannick Estevez, Stéphane Pelleau, Eric Legrand, Lise Musset, Christophe Duplais

Open access · goldAbstract read
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Louis-Jérôme LebaLaboratoire de parasitologie, CNR du paludisme, Institut Pasteur de la Guyane, Cayenne, French Guiana, France; UMR QualiSud, Université de Guyane, 97300 Cayenne, France.
Jean PopoviciMalaria Molecular Epidemiology Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia.
Yannick EstevezCNRS, UMR8172 EcoFoG, AgroParisTech, Cirad, INRA, Université des Antilles, Université de Guyane, 97300 Cayenne, French Guiana, France.
Stéphane PelleauLaboratoire de parasitologie, CNR du paludisme, Institut Pasteur de la Guyane, Cayenne, French Guiana, France.
Eric LegrandLaboratoire de parasitologie, CNR du paludisme, Institut Pasteur de la Guyane, Cayenne, French Guiana, France; Research Unit of Genetics and Genomics of Insect Vectors Institut Pasteur, Paris, France.
Lise MussetLaboratoire de parasitologie, CNR du paludisme, Institut Pasteur de la Guyane, Cayenne, French Guiana, France.
Christophe DuplaisCNRS, UMR8172 EcoFoG, AgroParisTech, Cirad, INRA, Université des Antilles, Université de Guyane, 97300 Cayenne, French Guiana, France. Electronic address: christophe.duplais@ecofog.gf.
Centre National de la Recherche Scientifique · FRInstitut Pasteur de la Guyane · GFInstitut Pasteur · FRInstitut Pasteur du Cambodge · KHUniversity of French Guiana · GF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The search for safe antimalarial compounds acting against asexual symptom-responsible stages and sexual transmission-responsible forms of Plasmodium species is one of the major challenges in malaria elimination programs. So far, among current drugs approved for human use, only primaquine has transmission-blocking activity. The discovery of small molecules targeting different Plasmodium falciparum life stages remains a priority in antimalarial drug research. In this context, several independent studies have recently reported antiplasmodial and transmission-blocking activities of commonly used stains, dyes and fluorescent probes against P. falciparum including chloroquine-resistant isolates. Herein we have studied the antimalarial activities of dyes with different scaffold and we report that the triarylmethane dye (TRAM) Brilliant green inhibits the growth of asexual stages (IC

Indexed as

Chromatography, LiquidColoring AgentsCulture MediaErythrocytesLife Cycle StagesLissamine Green DyesMalaria, FalciparumPlant ExtractsPlasmodium falciparumQuaternary Ammonium CompoundsRosaniline Dyesbrilliant greenColoring AgentsCulture Mediagreen 5Lissamine Green DyesPlant ExtractsQuaternary Ammonium CompoundsRosaniline Dyessulfan blueAntimalarial dyesBrilliant greenDrug uptakeFood dyesTransmission blockingTriarylmethanes

Identifiers

PMID28886443
PMCPMC5587875
OpenAlexW2740593163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.